期刊文献+

右乳腺癌保乳术后留置银夹对后程同步整合补量调强放射治疗瘤床靶区作用 被引量:4

Dosim etry study of silver clip marker on simultaneous integrated boost intensity modulated radiotherapy for right breast after breast-conserving surgery
在线阅读 下载PDF
导出
摘要 目的探讨右乳腺癌保乳术后有银夹标记瘤床同步整合补量调强放射治疗临床剂量学特点。方法选取行早期右乳腺癌保乳术后加放射治疗的女性患者30例.年龄25~61岁,中位年龄44.2岁。根据右乳腺癌保乳术中瘤床有无放置银夹分为有银夹组15例.无银夹组15例。给予调强放射治疗后程同步瘤床电子线补量照射,并比较两种方法的剂量学参数。结果无银夹组瘤床靶体积大于有银夹组.两者比较,差异有统计学意义(P〈0.05);两组全乳腺靶体积差异无统计学意义(P〉0.05).无银夹组瘤床靶体积与全乳腺靶体积比值大于有银夹组,差异有统计学意义(P〈0.05),两组瘤床靶体积平均厚度差异无统计学意义(P〉0.05);两组全乳腺靶区Dmax、Dmin和V95差异无统计学意义(P〉0.05),两组Dmean、V105和V110差异有统计学意义(P〈0.05);两组全乳腺靶区适形度和均匀指数差异无统计学意义(P〉0.05),瘤床靶区适形度差异有统计学意义(P〈0.05),瘤床靶区均匀指数差异无统计学意义(P〉0.05);右肺V5、V10、V20左肺Dmean、全肺V20,心脏V5,V15、Dmean,脊髓Dmax、左乳腺Dmean,两组比较,差异无统计学意义(P〉0.05)。结论有银夹组与无银夹组大部分剂量学参数差异无统计学意义.但有银夹组瘤床靶区体积及适形度方面比无银夹组有一定的优势。 Objective To study the clinical dosimetry characteristics of fight breast conserving surgery patients with silver clip marker on simultaneous integrated boost intensity modulated. Methods A total of 30 right breast conserving surgery female patients were enrolled, which aged 25 - 61 years old with median age of 44.2 years old. All of them were divided into 2 groups, silver clip marker group(n = 15) and without silver clip marker group(n = 15), which performed simultaneous integrated boost intensity modulated radiotherapy, and compared differences on dosimetry between 2 groups. Results On tumor bed tar- get volume(Vcrvl), the without silver clip marker group was larger than that of silver clip marker group, there was significant difference between 2 groups(P 〈 0.05). On whole breast target volume(VCTV), the difference was no significant between 2 groups (P 〉 0.05). In comparison with VCTV1/VCTV, the group without silver clip marker was obviously larger than that of silver clip marker group, there was significant difference between 2 groups(P 〈 0.05). There was no significant of mean thickness of tumor bed between 2 groups (P 〉 0.05). On Dmax, Dmin, V95 of target volume were no significant between 2 groups (P 〉 0.05), but Dneab, V105, V110 were significant difference (P 〈 0.05). On homogeneity index and conformal index of whole breast, there was signifi- cant difference between 2 groups (P 〈 0.05), and on conformal index of tumor bed target volume, there was significant differ- ence(P 〈 0.05), but on homogeneity index, there was no significants(P 〉 0.05). On V5, V10, V20 of fight lung, Dmean of left lung, V20 of whole lung, V5, V15 and Dmean of heart, Dmax of spinal cord and Dmean of left breast were no significant between 2 groups(P 〉 0.05). Conclusion It is demonstrated that the most of dosage parameters are no significant between silver clip marker group and without silver clip marker group, but silver clip marker group shows more advantages in tumor bed target volume and conformal index than without silver clip marker group.
出处 《生物医学工程与临床》 CAS 2016年第2期157-161,共5页 Biomedical Engineering and Clinical Medicine
关键词 乳腺癌 保乳术 银夹标记 同步电子线补量 调强放射治疗 瘤床靶区 breast cancer breast-conserving surgery silver clip marker simultaneous electronic lines boost intensity-modu-lated radiotherapy tumor bed target volume
作者简介 张凯恋(1991-),女,湖北咸宁市人,硕士研究生,主要从事肿瘤放射治疗工作。电话:0871—68199684。E-mail:yiyangrt@126.com。 通讯作者:杨毅(1965-),男,云南昆明市人(彝族),硕士,主任医师,硕导,主要从事肿瘤放疗的基础与临床方面的研究。E-mail:yiyangrt@126.com。
  • 相关文献

参考文献12

  • 1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
  • 2陈万青,郑荣寿,曾红梅,邹小农,张思维,赫捷.2011年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2015,24(1):1-10. 被引量:869
  • 3Beckham WA, Popescu CC, Patenaude VV, et al. Is multibeam IMRT better than standard treatment for patients with left- sided breast cancer[J]? Int J Radiat Oncol Biol Phys, 2007, 69 (3): 918-924.
  • 4Polgar C, Fodor J, Major T, et al. The role of boost irradia- tion in the conservative treatment of stage Ⅰ , Ⅱ breast can-cer[J]. Pathol Oncol Res, 2001, 7(4): 241-250.
  • 5李建彬,徐敏,于金明.乳腺癌放射治疗研究现状[J].中华放射肿瘤学杂志,2003,12(2):124-127. 被引量:21
  • 6Guerrero M, Li XA, Earl MA, et al. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study [J]. Int J Radiat Oncol Biol Phys, 2004, 59(5): 1513-1522.
  • 7李楠,李光,赵欣宇,张硕,夏兵,王志宇.乳腺癌保乳术后切线野照射与瘤床同步整合补量调强放射治疗的剂量学区别[J].中国医科大学学报,2011,40(7):635-638. 被引量:11
  • 8李建彬,马志芳,卢洁,王永胜,于金明,刘娟,姚春萍.乳腺癌保留乳房术后瘤床同步X射线和电子线整合补量调强放疗剂量研究[J].中华放射医学与防护杂志,2006,26(5):479-482. 被引量:10
  • 9Association of Breast Surgery at Baso 2009. Surgical guide- lines for the management of breast cancer[J]. Eur J Surg On- col, 2009, 35(Suppl 1): 1-22.
  • 10Coles CE, Wilson CB, Cumming J, et al. Titanium clip placement to allow accurate turnout bed localization following breast con- serving surgery: audit on behalf of the IMPORT Trial Manage- ment Group[J]. Eur J Surg Oncol, 2009, 35(6): 578-582.

二级参考文献29

  • 1李建彬,马志芳,卢洁,王永胜,于金明,刘娟,姚春萍.乳腺癌保留乳房术后瘤床同步X射线和电子线整合补量调强放疗剂量研究[J].中华放射医学与防护杂志,2006,26(5):479-482. 被引量:10
  • 2杨昭志,陈佳艺,俞晓立.动态CT评价早期乳腺癌保乳术后全乳 照射期间瘤床体积变化的时间规律并评价基于金属夹进行瘤床加量的准确性[C].中华医学会放射肿瘤治疗学分会六届二次暨中国抗癌协会肿瘤放疗专业委员会二届二次学术会议论文集, 2009:294-295.
  • 3Whelan T, Levine M. Radiation therapy following breast conservation surgery: Can it ever be avoided?[J]. Annals of Oncology, 1997,8(3): 217-218.
  • 4Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy versus lumpectomy for small size breast cancer[J]. European Journal of Cancer, 1990, 26(6): 671-673.
  • 5Poortmans PM, Collette L, Bartelink H, et al. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserv-ing treatment for breast cancer. A summary of' the results of EORTC 22881-10882 "boost versus no boost" trial [J].Cancer Radiother, 2008, 12(6-7) :565-570.
  • 6Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a ran- domized trial comparing total mastectomy, lumpeetomy, and lumpec- tomy plus irradiation for the treatment of invasive breast caneer[J].N Engl J Med, 2002,347 ( 16 ) : 1233-1241.
  • 7Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer [J]. N Engl J Med,2002,347 (16) : 1227-1232.
  • 8Vieini FA, Sharpe M, Kestin L, et al.Optimizing breast cancer treat- ment efficacy with intensity-modulated radiotherapy [J].Int J Radiat Oncol Bio| Phys, 2002,54(5 ) : 1336-1344.
  • 9Donovan E, Bleakley N, Denholm E, et al.Randomised trial of stan- dard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy[J].Radiother Oneol. 2007.82( 3 ): 254-264.
  • 10Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to irn- prove dose uniformity with tangential breast radiotherapy:initial clinical experience [ J ]. Int J Radiat Oncol Biol Phys, 2000,48( 5 ) : 1559-1568.

共引文献901

同被引文献38

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部